120 related articles for article (PubMed ID: 10150468)
1. Detection of undiagnosed coagulopathies using routine rapid heparin neutralization.
Burns ER; Lee V; Wenz B
Clin Lab Sci; 1995; 8(2):113-6. PubMed ID: 10150468
[TBL] [Abstract][Full Text] [Related]
2. Causes of isolated prolonged activated partial thromboplastin time in an acute care general hospital.
Chng WJ; Sum C; Kuperan P
Singapore Med J; 2005 Sep; 46(9):450-6. PubMed ID: 16123828
[TBL] [Abstract][Full Text] [Related]
3. Coagulopathy screening in children with heparinized central venous catheters.
Ellis MR
Pediatrics; 1993 Jun; 91(6):1147-50. PubMed ID: 8502518
[TBL] [Abstract][Full Text] [Related]
4. Elevated activated partial thromboplastin time does not correlate with heparin rebound following cardiac surgery.
Taneja R; Marwaha G; Sinha P; Quantz M; Stitt L; Gao R; Subramanian S; Schaus M; Keeney M; Chin-Yee I; Murkin J
Can J Anaesth; 2009 Jul; 56(7):489-96. PubMed ID: 19408066
[TBL] [Abstract][Full Text] [Related]
5. Use of an automated coagulation analyzer to perform heparin neutralization with polybrene in blood samples for routine coagulation testing: practical, rapid, and inexpensive.
Tientadakul P; Kongkan C; Chinswangwatanakul W
Arch Pathol Lab Med; 2013 Nov; 137(11):1641-7. PubMed ID: 24168503
[TBL] [Abstract][Full Text] [Related]
6. Acquired coagulation disorders: revisited using global coagulation/anticoagulation testing.
Tripodi A; Chantarangkul V; Mannucci PM
Br J Haematol; 2009 Oct; 147(1):77-82. PubMed ID: 19659548
[TBL] [Abstract][Full Text] [Related]
7. On the value of the activated partial thrombo-plastin time (aptt) in monitoring heparin therapy.
Teien AN; Abildgaard U
Thromb Haemost; 1976 Jun; 35(3):592-7. PubMed ID: 989966
[TBL] [Abstract][Full Text] [Related]
8. Contact factor deficiencies and cardiopulmonary bypass surgery: detection of the defect and monitoring of heparin.
van Veen JJ; Laidlaw S; Swanevelder J; Harvey N; Watson C; Kitchen S; Makris M
Eur J Haematol; 2009 Mar; 82(3):208-12. PubMed ID: 19077049
[TBL] [Abstract][Full Text] [Related]
9. [Study on usefulness of different APTT test kit in variable coagulopathy].
Naito S; Ieko M; Yoshida M; Tarumi T; Nakabayashi T; Nishio H; Atsumi T
Rinsho Byori; 2008 Mar; 56(3):195-202. PubMed ID: 18411803
[TBL] [Abstract][Full Text] [Related]
10. Filtered plasma as a potential cause of clinical misdiagnosis: inappropriate testing in a haematology laboratory.
Favaloro EJ; Mohammed A; Coombs R; Mehrabani PA
Br J Biomed Sci; 1995 Dec; 52(4):243-8. PubMed ID: 8555777
[TBL] [Abstract][Full Text] [Related]
11. Rapid removal of heparin from plasma by affinity filtration.
Wenz B; Burns ER
Am J Clin Pathol; 1991 Sep; 96(3):385-90. PubMed ID: 1877538
[TBL] [Abstract][Full Text] [Related]
12. [Effect of reagent batch on activated partial thromboplastin time in canine plasma and use of the ratio system for standardization].
Mischke R
Berl Munch Tierarztl Wochenschr; 2002; 115(5-6):225-9. PubMed ID: 12058600
[TBL] [Abstract][Full Text] [Related]
13. Standardization of coagulation tests.
Opartkiattikul N
Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 3():79-85. PubMed ID: 10926265
[TBL] [Abstract][Full Text] [Related]
14. Utility of activated partial thromboplastin time waveform analysis for identification of sepsis and overt disseminated intravascular coagulation in patients admitted to a surgical intensive care unit.
Dempfle CE; Lorenz S; Smolinski M; Wurst M; West S; Houdijk WP; Quintel M; Borggrefe M
Crit Care Med; 2004 Feb; 32(2):520-4. PubMed ID: 14758173
[TBL] [Abstract][Full Text] [Related]
15. Comparing the results of coagulation tests on blood drawn by venipuncture and through heparinized tunneled venous access devices in pediatric patients with cancer.
Hinds PS; Quargnenti A; Gattuso J; Kumar Srivastova D; Tong X; Penn L; West N; Cathey P; Hawkins D; Wilimas J; Starr M; Head D
Oncol Nurs Forum; 2002 Apr; 29(3):E26-34. PubMed ID: 11979291
[TBL] [Abstract][Full Text] [Related]
16. The monitoring of heparin administration by screening tests in experimental dogs.
Mischke R; Jacobs C
Res Vet Sci; 2001 Apr; 70(2):101-8. PubMed ID: 11356088
[TBL] [Abstract][Full Text] [Related]
17. [Correlation between plasma concentration of heparin and biological response determined by 2 APTT reagents of different sensitivities].
Bassini E; Miceli M; Cini S; Francalanci R
Quad Sclavo Diagn; 1986 Jun; 22(2):193-200. PubMed ID: 3823368
[TBL] [Abstract][Full Text] [Related]
18. Use of the activated partial thromboplastin time for heparin monitoring.
Smythe MA; Koerber JM; Westley SJ; Nowak SN; Begle RL; Balasubramaniam M; Mattson JC
Am J Clin Pathol; 2001 Jan; 115(1):148-55. PubMed ID: 11190801
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a point-of-care coagulation analyzer (Abaxis VSPro) for identification of coagulopathies in dogs.
Dixon-Jimenez AC; Brainard BM; Cathcart CJ; Koenig A
J Vet Emerg Crit Care (San Antonio); 2013; 23(4):402-7. PubMed ID: 23796019
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of high-concentration calcium chloride solution for correction of activated partial thromboplastin time (APTT) in patients with high-hematocrit value.
Kanahara M; Kai H; Okamura T; Wada T; Suda K; Imaizumi T; Sagawa K
Thromb Res; 2008; 121(6):781-5. PubMed ID: 17904620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
